🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Nonsmall Cell Lung Cancer Stage III

Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation NCT05010109NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: 6 Minute Walk Functional Test, Biospecimen Collection, Computed Tomography, Echocardiography, Exercise Cardiac Stress T… A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC NCT06424899Phase 21 site📍 Hangzhou Zeng Jian · Tests: Adebrelimab, radical chemoradiotherapy, Platinum based chemotherapy Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients NCT06634199n/a22 sites📍 Ferrol📍 Alicante📍 Badalona Fundación GECP · Tests: Durvalumab Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC NCT06878274Phase 21 site📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Post-operative radiotherapy GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer NCT07017829Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Anti-CFH Monoclonal Antibody GT103, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation NCT07012031Phase 1, Phase 29 sites📍 Sacramento📍 Tampa📍 Tampa National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer NCT05502523NA4 sites📍 Abington📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Pulmonary Artery-First Surgical Technique, Biospecimen Collection Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer NCT07410975Phase 21 site📍 Shanghai Shanghai Pulmonary Hospital, Shanghai, China · Tests: sintilimab+IBI310+chemotherapy Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy NCT05468242Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Neoadjuvant chemo-immunotherapy, Bevacizumab, Radiotherapy, Tislelizumab Understanding the Feasibility of a Co-designed Pre-radiotherapy Exercise Programme - A Single-arm Study NCT07554677NA1 site📍 Belfast Queen's University, Belfast · Tests: Exercise, radiotherapy Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC) NCT07153445Phase 221 sites📍 Alicante📍 Badalona📍 Barcelona Fundación GECP · Tests: Atezolizumab, Paclitaxel, Carboplatin Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study NCT07405086Phase 41 site📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Immune Checkpoint Inhibitor Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC NCT07528066n/a10 sites📍 Fuzhou📍 Guangzhou📍 Shenzhen Shanghai Chest Hospital · Tests: Robotic-assisted surgery (RATS) To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy NCT04853342Phase 31 site📍 Suzhou Allist Pharmaceuticals, Inc. · Tests: Drug: Furmonertinib 80 mg, Furmonertinib 80 mg placebo Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) NCT07149649Phase 2, Phase 311 sites📍 Aarau📍 Aarau📍 Baden Swiss Cancer Institute · Tests: Magnesiocard, Magnesium Diasporal, Microcrystalline cellulose, Isotonic saline solution 0.9% Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer NCT06656598Phase 225 sites📍 Angers📍 Angers📍 Avignon Intergroupe Francophone de Cancerologie Thoracique · Tests: Carboplatin, Paclitaxel, Cemiplimab, Curative hypofractionated radiotherapy, Cemiplimab (maintenance) A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab NCT07391670Phase 119 sites📍 Fitzroy📍 St Albans📍 Woolloongabba AstraZeneca · Tests: SC durvalumab + rHu, IV durvalumab, Tremelimumab Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC NCT03872661Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: IBI308, Bevacizumab, Pemetrexed, Carboplatin, Thoracic surgery Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer NCT04728724Phase 21 site📍 Shanghai Shanghai Pulmonary Hospital, Shanghai, China · Tests: Sintilimab, Chemotherapy Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial NCT07388524Phase 3110 sites📍 Beverly Hills📍 Los Angeles📍 Tarzana National Cancer Institute (NCI) · Tests: Atezolizumab, Atezolizumab and Recombinant Human Hyaluronidase, Biospecimen Collection, Computed Tomography, Patient Ob… A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer NCT04951635Phase 31 site📍 Ji'nan Jiangsu Hansoh Pharmaceutical Co., Ltd. · Tests: Almonertinib, Placebo Almonertinib PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC NCT06102057Phase 211 sites📍 Dresden📍 Essen📍 Freiburg im Breisgau TheraOp · Tests: standard Radiotherapy, Chemotherapy, Immunotherapy, Experimental Radiotherapy Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial NCT06500481Phase 358 sites📍 Phoenix📍 Little Rock📍 Encinitas NRG Oncology · Tests: Biospecimen Collection, Computed Tomography, Involved-Field Radiation Therapy, Lumbar Puncture, Magnetic Resonance Imag… Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients NCT06114108NA7 sites📍 Aarau📍 Bellinzona📍 Chur Swiss Cancer Institute · Tests: Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy), Surgery, Radiotherapy The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients NCT07138755Phase 24 sites📍 Changsha📍 Changsha📍 Hengyang The Third Xiangya Hospital of Central South University · Tests: Experimental A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer NCT06122064NA1 site📍 Rochester Mayo Clinic · Tests: Best Practice, Communication Intervention, Electronic Health Record Review, Survey Administration, Video Recording Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) NCT06437977Phase 31 site📍 Shanghai Shanghai Chest Hospital · Tests: SBRT, Toripalimab Osimertinib With or Without Primary Lung Tumor Resection for EGFR-Mutant Oligometastatic Non-Small Cell Lung Cancer NCT07738172Phase 31 site📍 Taipei National Taiwan University Hospital · Tests: Primary Tumor Resection, Osimertinib Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer NCT05501665Phase 1, Phase 21 site📍 Nashville Vanderbilt-Ingram Cancer Center · Tests: Biospecimen Collection, Carboplatin, Computed Tomography, Fludeoxyglucose F-18, Nab-paclitaxel Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer NCT07632365Phase 1, Phase 21 site📍 Shanghai Shanghai Chest Hospital · Tests: Induction chemoimmunotherapy, Concurrent chemoradiotherapy (cCRT), consolidation immunotherapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy